Introduction: Mortality in dialysis patients is higher than in the general population, and cardiovascular disease represents the leading cause of death. Hypertension and volume overload are important risk factors for the development of left ventricular hypertrophy (LVH) in hemodialysis (HD) and peritoneal dialysis (PD) patients. Other factors are mainly represented by hyperparathyroidism, vascular calcification, arterial stiffness and inflammation. The aim of this study was to compare blood pressure (BP) and metabolic parameters with cardiovascular changes [cardiothoracic ratio (CTR), aortic arch calcification (AAC) and LV mass index (LVMI)] between PD and HD patients. Materials and Methods: 45 patients (23 HD and 22 PD patients) were ...
♦ Background: It is still not clear whether hypertension and left ventricular hypertrophy (LVH) are ...
Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients. Cardi...
Cardiovascular diseases are a major cause of morbidity and mortality in patients with end-stage rena...
Introduction. The aim of this study was to evaluate ventricular geometry, its relationship with the ...
♦ Objective: To examine the relation between the results of ambulatory 24-hour blood pressure monito...
OBJECTIVE: In this study, we aimed to compare the cardiovascular risk factors that might be associat...
Introduction: Arterial stiffness is a risk marker for cardiovascular events in peritoneal dialysis (...
Cardiovascular events (CVE) are the major cause of death in hemodialysis patients (HDP). Hypertensio...
In this study we compared the influence of 2 different modalities of treatment, CAPD and hemodialysi...
Cardiovascular disease is responsible for at least half of all deaths in end-stage renal disease pat...
C-reactive protein (CRP), the prototype marker of inflammation, and cardiac hypertrophy are importan...
BACKGROUND: The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
Cardiovascular diseases are the major cause of mortality in uraemic patients treated by hemodialysis...
C ardiovascular disease remains the most common cause of mortality for patients with end-stage renal...
Background: The majority of haemodialysis (HD) patients gain weight between dialysis sessions and th...
♦ Background: It is still not clear whether hypertension and left ventricular hypertrophy (LVH) are ...
Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients. Cardi...
Cardiovascular diseases are a major cause of morbidity and mortality in patients with end-stage rena...
Introduction. The aim of this study was to evaluate ventricular geometry, its relationship with the ...
♦ Objective: To examine the relation between the results of ambulatory 24-hour blood pressure monito...
OBJECTIVE: In this study, we aimed to compare the cardiovascular risk factors that might be associat...
Introduction: Arterial stiffness is a risk marker for cardiovascular events in peritoneal dialysis (...
Cardiovascular events (CVE) are the major cause of death in hemodialysis patients (HDP). Hypertensio...
In this study we compared the influence of 2 different modalities of treatment, CAPD and hemodialysi...
Cardiovascular disease is responsible for at least half of all deaths in end-stage renal disease pat...
C-reactive protein (CRP), the prototype marker of inflammation, and cardiac hypertrophy are importan...
BACKGROUND: The K/DOQI guideline for bone metabolism and disease in chronic kidney disease is predom...
Cardiovascular diseases are the major cause of mortality in uraemic patients treated by hemodialysis...
C ardiovascular disease remains the most common cause of mortality for patients with end-stage renal...
Background: The majority of haemodialysis (HD) patients gain weight between dialysis sessions and th...
♦ Background: It is still not clear whether hypertension and left ventricular hypertrophy (LVH) are ...
Blood pressure, left ventricular hypertrophy and long-term prognosis in hemodialysis patients. Cardi...
Cardiovascular diseases are a major cause of morbidity and mortality in patients with end-stage rena...